doi: 10.3389/fchem.2025.1536858 Received 29 November 2024 Accepted 27 January 2025 Published 19 March 2025 Volume 13 - 2025 Edited by Federica Aureli, National Institute of Health (ISS), Italy Reviewed by Eric Deconinck, Sciensano (Belgium), Belgium Maria Cristina Gaudiano, National Institute of Health (ISS), Italy Updates Copyright 2025 Blazewicz, Poplawska, Daniszewska, Piorunska and Karynski
For menopausal women specifically, interactions with hormone replacement therapy should be discussed with a healthcare provider, as both HRT and certain peptides affect metabolic and hormonal pathways
The decision should always be made in consultation with your provider
Medication access within Measureds program is intentionally framed with limited specificity before intake, with most details resolving only after clinician review